These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 12892901)

  • 1. Elevated C-reactive protein levels during first trimester of pregnancy are indicative of preeclampsia and intrauterine growth restriction.
    Tjoa ML; van Vugt JM; Go AT; Blankenstein MA; Oudejans CB; van Wijk IJ
    J Reprod Immunol; 2003 Jun; 59(1):29-37. PubMed ID: 12892901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First-trimester maternal serum levels of placenta growth factor as predictor of preeclampsia and fetal growth restriction.
    Ong CY; Liao AW; Cacho AM; Spencer K; Nicolaides KH
    Obstet Gynecol; 2001 Oct; 98(4):608-11. PubMed ID: 11576576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated maternal levels of the long pentraxin 3 (PTX3) in preeclampsia and intrauterine growth restriction.
    Cetin I; Cozzi V; Pasqualini F; Nebuloni M; Garlanda C; Vago L; Pardi G; Mantovani A
    Am J Obstet Gynecol; 2006 May; 194(5):1347-53. PubMed ID: 16647920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma placenta growth factor levels in midtrimester pregnancies.
    Tjoa ML; van Vugt JM; Mulders MA; Schutgens RB; Oudejans CB; van Wijk IJ
    Obstet Gynecol; 2001 Oct; 98(4):600-7. PubMed ID: 11576575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoglin in pregnancy complicated by fetal intrauterine growth restriction in normotensive and preeclamptic pregnant women: a comparison between preeclamptic patients with appropriate-for-gestational-age weight infants and healthy pregnant women.
    Laskowska M; Laskowska K; Oleszczuk J
    J Matern Fetal Neonatal Med; 2012 Jun; 25(6):806-11. PubMed ID: 21793708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal serum-soluble vascular endothelial growth factor receptor-1 in early pregnancy ending in preeclampsia or intrauterine growth retardation.
    Wathén KA; Tuutti E; Stenman UH; Alfthan H; Halmesmäki E; Finne P; Ylikorkala O; Vuorela P
    J Clin Endocrinol Metab; 2006 Jan; 91(1):180-4. PubMed ID: 16263826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal Cadmium Levels During Pregnancy and the Relationship with Preeclampsia and Fetal Biometric Parameters.
    Wang F; Fan F; Wang L; Ye W; Zhang Q; Xie S
    Biol Trace Elem Res; 2018 Dec; 186(2):322-329. PubMed ID: 29651732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First trimester maternal serum analytes and second trimester uterine artery Doppler in the prediction of preeclampsia and fetal growth restriction.
    Yu N; Cui H; Chen X; Chang Y
    Taiwan J Obstet Gynecol; 2017 Jun; 56(3):358-361. PubMed ID: 28600048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiogenic factors in maternal circulation and preeclampsia with or without fetal growth restriction.
    Vatten LJ; Åsvold BO; Eskild A
    Acta Obstet Gynecol Scand; 2012 Dec; 91(12):1388-94. PubMed ID: 22882089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second-trimester plasma homocysteine levels and pregnancy-induced hypertension, preeclampsia, and intrauterine growth restriction.
    Hogg BB; Tamura T; Johnston KE; Dubard MB; Goldenberg RL
    Am J Obstet Gynecol; 2000 Oct; 183(4):805-9. PubMed ID: 11035317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of maternal serum CRP, IL-6, TNF-alpha, homocysteine, folic acid and vitamin B12 levels with the severity of preeclampsia and fetal birth weight.
    Guven MA; Coskun A; Ertas IE; Aral M; Zencirci B; Oksuz H
    Hypertens Pregnancy; 2009 May; 28(2):190-200. PubMed ID: 19437229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes of dimeric inhibin B levels in maternal serum throughout healthy gestation and in women with gestational diseases.
    Petraglia F; Luisi S; Benedetto C; Zonca M; Florio P; Casarosa E; Volpe A; Bernasconi S; Genazzani AR
    J Clin Endocrinol Metab; 1997 Sep; 82(9):2991-5. PubMed ID: 9284732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First trimester PTX3 levels in women who subsequently develop preeclampsia and fetal growth restriction.
    Cetin I; Cozzi V; Papageorghiou AT; Maina V; Montanelli A; Garlanda C; Thilaganathan B
    Acta Obstet Gynecol Scand; 2009; 88(7):846-9. PubMed ID: 19544202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levels of asymmetric dimethylarginine throughout normal pregnancy and in pregnancies complicated with preeclampsia or had a small for gestational age baby.
    Rizos D; Eleftheriades M; Batakis E; Rizou M; Haliassos A; Hassiakos D; Botsis D
    J Matern Fetal Neonatal Med; 2012 Aug; 25(8):1311-5. PubMed ID: 22010788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasminogen activator of urokinase type and its inhibitor of placental type in hypertensive pregnancies and in intrauterine growth retardation: possible markers of placental function.
    Lindoff C; Astedt B
    Am J Obstet Gynecol; 1994 Jul; 171(1):60-4. PubMed ID: 8030735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin resistance and alterations in angiogenesis: additive insults that may lead to preeclampsia.
    Thadhani R; Ecker JL; Mutter WP; Wolf M; Smirnakis KV; Sukhatme VP; Levine RJ; Karumanchi SA
    Hypertension; 2004 May; 43(5):988-92. PubMed ID: 15023932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma IL-4, IL-8, IL-12, interferon-γ and CRP levels in pregnant women with preeclampsia, and their relation with severity of disease and fetal birth weight.
    Cemgil Arikan D; Aral M; Coskun A; Ozer A
    J Matern Fetal Neonatal Med; 2012 Sep; 25(9):1569-73. PubMed ID: 22185464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma homocysteine in early and late pregnancies complicated with preeclampsia and isolated intrauterine growth restriction.
    D'Anna R; Baviera G; Corrado F; Ientile R; Granese D; Stella NC
    Acta Obstet Gynecol Scand; 2004 Feb; 83(2):155-8. PubMed ID: 14756732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased free fetal DNA levels in early pregnancy plasma of women who subsequently develop preeclampsia and intrauterine growth restriction.
    Illanes S; Parra M; Serra R; Pino K; Figueroa-Diesel H; Romero C; Arraztoa JA; Michea L; Soothill PW
    Prenat Diagn; 2009 Dec; 29(12):1118-22. PubMed ID: 19816882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased human placental growth hormone at midtrimester pregnancies may be an index of intrauterine growth retardation related to preeclampsia.
    Papadopoulou E; Sifakis S; Giahnakis E; Fragouli Y; Karkavitsas N; Koumantakis E; Kalmanti M
    Growth Horm IGF Res; 2006; 16(5-6):290-6. PubMed ID: 16996762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.